| Authors | Daniel E Furst, Edward Clark Keystone, Alexander K So, Jürgen Braun, Ferry C Breedveld, Gerd R Burmester, Fabrizio De Benedetti, Thomas Dörner, Paul Emery, Roy Fleischmann, Allan Gibofsky, J R Kalden, Arthur Kavanaugh, Bruce Kirkham, Philip Mease, A Rubbert-Roth, Joachim Sieper, Nora G Singer, Josef S Smolen, Piet L C M Van Riel, Michael H Weisman, Kevin L Winthrop |
| Journal | Annals of the rheumatic diseases
(Ann Rheum Dis)
Vol. 72 Suppl 2
Pg. ii2-34
(Apr 2013)
ISSN: 1468-2060 [Electronic] England |
| PMID | 23532441
(Publication Type: Consensus Development Conference, Journal Article)
|
| Chemical References |
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents
- Immunoconjugates
- Immunosuppressive Agents
- Tumor Necrosis Factor-alpha
- Polyethylene Glycols
- belimumab
- Abatacept
- Urate Oxidase
- tocilizumab
- Pegloticase
|
| Topics |
- Abatacept
- Antibodies, Monoclonal, Humanized
(adverse effects, therapeutic use)
- Antirheumatic Agents
(adverse effects, therapeutic use)
- Female
- Humans
- Immunoconjugates
(adverse effects, therapeutic use)
- Immunosuppressive Agents
(adverse effects, therapeutic use)
- Male
- Polyethylene Glycols
(adverse effects, therapeutic use)
- Pregnancy
- Rheumatic Diseases
(complications, drug therapy)
- Treatment Outcome
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors)
- Urate Oxidase
(adverse effects, therapeutic use)
|
